142 related articles for article (PubMed ID: 7184670)
1. Comparative bioavailability of chlorpropamide tablet and suspension formulations.
Batenhorst RL; Bustrack JA; Bivins BA; Foster TS
Clin Pharm; 1982; 1(1):58-61. PubMed ID: 7184670
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability study with two chlorpropamide tablet formulations in healthy volunteers.
da Silva MA; Mendes FD; de Oliveira RA; Monif T; Patni A; Reyar S; Mendes GD; De Nucci G
Arzneimittelforschung; 2007; 57(9):591-8. PubMed ID: 17966758
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of indomethacin tablets in men volunteers.
Groth PE; Dunn JM
Clin Pharm; 1986 Oct; 5(10):820-4. PubMed ID: 3780150
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
Hatorp V; Oliver S; Su CA
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability of two suspension formulations of potassium diclofenac in healthy male volunteers.
Mendes GB; Franco LM; Moreno RA; Fernandes AG; Muscara MN; de Nucci G
Int J Clin Pharmacol Ther; 1994 Mar; 32(3):131-5. PubMed ID: 8205374
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability of two tablet formulations of acyclovir in healthy volunteers.
Al-Yamani MJ; Al-Khamis KI; El-Sayed YM; Bawazir SA; Al-Rashood KA; Gouda MW
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):222-6. PubMed ID: 9587049
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability of single doses of tablet formulations of cetirizine dihydrochloride in healthy male volunteers.
Muscará MN; de Nucci G
Int J Clin Pharmacol Ther; 1995 Jan; 33(1):27-31. PubMed ID: 7711987
[TBL] [Abstract][Full Text] [Related]
12. Palatability and relative bioavailability of an extemporaneous carbamazepine oral suspension.
Bloomer D; Dupuis LL; MacGregor D; Soldin SJ
Clin Pharm; 1987 Aug; 6(8):646-9. PubMed ID: 3691011
[TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability of two brands of chlorpropamide in Kenyans.
Ondari CO; Kibwage IO; Ndemo FA; McLigeyo SI
East Afr Med J; 1989 Oct; 66(10):663-8. PubMed ID: 2612406
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products.
Williams BO; Liao SH; Lai AA; Arnold JD; Perkins JG; Blum MR; Findlay JW
Clin Pharm; 1984; 3(6):638-43. PubMed ID: 6509877
[TBL] [Abstract][Full Text] [Related]
16. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
[TBL] [Abstract][Full Text] [Related]
18. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers.
Bawazir SA; Gouda MW; El-Sayed YM; Al-Khamis KI; Al-Yamani MJ; Niazy EM; Al-Rashood KA
Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of ergoloid mesylates liquid capsule.
Schran HF
Clin Ther; 1985; 8(1):71-5. PubMed ID: 3833371
[TBL] [Abstract][Full Text] [Related]
20. A study in normal human volunteers to compare the rate and extent of levothyroxine absorption from Synthroid and Levoxine.
Berg JA; Mayor GH
J Clin Pharmacol; 1992 Dec; 32(12):1135-40. PubMed ID: 1487553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
